drugset / Trial / NCT00664664
Subjective Study to Assess the Efficacy of APD125 in Patients With Sleep Maintenance Insomnia
RandomizedParallel-groupQuadruple-blindTreatment
Summary
This study is designed to compare 2 doses of APD125 (20 mg and 40 mg) with placebo in otherwise healthy adults with primary insomnia primarily with complaints of maintaining sleep. Participants will be required to maintain a daily sleep dairy for up to 3 weeks while on study.
Timeline
- Start
- 2008-04
- Primary completion
- 2008-10
- Completion
- 2008-11
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Nelotanserin | Small molecule | 20 mg | — |
| Subject | Nelotanserin | Small molecule | 40 mg | — |